These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37830597)

  • 1. Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus.
    Garcia G; Chakravarty N; Paiola S; Urena E; Gyani P; Tse C; French SW; Danielpour M; Breunig JJ; Nathanson DA; Arumugaswami V
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
    Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
    mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells.
    Victorio CBL; Novera W; Ganasarajah A; Ong J; Thomas M; Wu J; Toh HSY; Sun AX; Ooi EE; Chacko AM
    J Transl Med; 2024 Feb; 22(1):126. PubMed ID: 38308299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic Zika Virus: New Option for Glioblastoma Treatment.
    Zhou C; Chen Q; Chen Y; Qin CF
    DNA Cell Biol; 2023 Jun; 42(6):267-273. PubMed ID: 36350682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy.
    Calderón-Peláez MA; Maradei Anaya SJ; Bedoya-Rodríguez IJ; González-Ipuz KG; Vera-Palacios D; Buitrago IV; Castellanos JE; Velandia-Romero ML
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zika virus has oncolytic activity against glioblastoma stem cells.
    Zhu Z; Gorman MJ; McKenzie LD; Chai JN; Hubert CG; Prager BC; Fernandez E; Richner JM; Zhang R; Shan C; Tycksen E; Wang X; Shi PY; Diamond MS; Rich JN; Chheda MG
    J Exp Med; 2017 Oct; 214(10):2843-2857. PubMed ID: 28874392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.
    Nair S; Mazzoccoli L; Jash A; Govero J; Bais SS; Hu T; Fontes-Garfias CR; Shan C; Okada H; Shresta S; Rich JN; Shi PY; Diamond MS; Chheda MG
    JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment.
    Francipane MG; Douradinha B; Chinnici CM; Russelli G; Conaldi PG; Iannolo G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma.
    Xiao J; Liang J; Fan J; Hou P; Li X; Zhang H; Li K; Bu L; Li P; He M; Zhong Y; Guo L; Jia P; Xiao Q; Wu J; Peng H; Li C; Xing F; Guo D
    Cancer Res; 2022 Sep; 82(18):3359-3374. PubMed ID: 35792620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells
    Kaid C; Goulart E; Caires-Júnior LC; Araujo BHS; Soares-Schanoski A; Bueno HMS; Telles-Silva KA; Astray RM; Assoni AF; Júnior AFR; Ventini DC; Puglia ALP; Gomes RP; Zatz M; Okamoto OK
    Cancer Res; 2018 Jun; 78(12):3363-3374. PubMed ID: 29700002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic Effect of Zika Virus in Neuroendocrine Pancreatic Tumors: New Perspectives for Therapeutic Approaches.
    Cocco MM; Carcione C; Miceli V; Tinnirello R; Chinnici CM; Carbone C; Zito G; Conaldi PG; Iannolo G
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors.
    Novaes GM; Lima C; Longo C; Machado PH; Silva TP; Olberg GGO; Módolo DG; Pereira MCL; Santos TG; Zatz M; Lagares D; de Franco M; Ho PL; Bulstrode H; Okamoto OK; Kaid C
    Mol Ther; 2024 Feb; 32(2):440-456. PubMed ID: 38213031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.
    Kanai R; Wakimoto H; Martuza RL; Rabkin SD
    Clin Cancer Res; 2011 Jun; 17(11):3686-96. PubMed ID: 21505062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin α
    Zhu Z; Mesci P; Bernatchez JA; Gimple RC; Wang X; Schafer ST; Wettersten HI; Beck S; Clark AE; Wu Q; Prager BC; Kim LJY; Dhanwani R; Sharma S; Garancher A; Weis SM; Mack SC; Negraes PD; Trujillo CA; Penalva LO; Feng J; Lan Z; Zhang R; Wessel AW; Dhawan S; Diamond MS; Chen CC; Wechsler-Reya RJ; Gage FH; Hu H; Siqueira-Neto JL; Muotri AR; Cheresh DA; Rich JN
    Cell Stem Cell; 2020 Feb; 26(2):187-204.e10. PubMed ID: 31956038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
    Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL
    Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma.
    Sherwood M; Zhou Y; Sui Y; Wang Y; Skipp P; Kaid C; Gray J; Okamoto K; Ewing RM
    F1000Res; 2023; 12():719. PubMed ID: 38903860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells.
    Trus I; Berube N; Jiang P; Rak J; Gerdts V; Karniychuk U
    Viruses; 2020 May; 12(5):. PubMed ID: 32466170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Serial Systemic and Intratumoral Injections of Oncolytic ZIKV
    Ferreira RO; Granha I; Ferreira RS; Bueno HS; Okamoto OK; Kaid C; Zatz M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts.
    Cheema TA; Kanai R; Kim GW; Wakimoto H; Passer B; Rabkin SD; Martuza RL
    Clin Cancer Res; 2011 Dec; 17(23):7383-93. PubMed ID: 21976549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
    Esaki S; Nigim F; Moon E; Luk S; Kiyokawa J; Curry W; Cahill DP; Chi AS; Iafrate AJ; Martuza RL; Rabkin SD; Wakimoto H
    Int J Cancer; 2017 Dec; 141(11):2348-2358. PubMed ID: 28801914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.